The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
Initiative aims to strengthen South-South collaboration and capacity building in biomedical research
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
Lifts full-year outlook as obesity drug boom accelerates
The twin designations are designed to speed up the development and review of promising medicines targeting serious conditions with high unmet need
Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
After Phase 3 results show major hair regrowth gains
The submission is backed by positive results from the Phase 3 AFFIRM study
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
